ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Aurora, CO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Cancer
Ovarian Cancer
Colorectal Cancer
Squamous Cell Carcinoma of Head and Neck

Breast Cancer trials near Aurora, CO, USA:

DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)

Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, Estrogen Receptor positive, HER-2 negative breast...

Active, not recruiting
Breast Cancer
Drug: Adjuvant Therapy
Drug: Palbociclib

Phase 2

Criterium

Aurora, Colorado, United States and 18 other locations

of sapanisertib and serabelisib (PIKTOR) with fulvestrant and/or other anticancer therapies in participants with HR+/HER2- advanced/metastatic breast...

Enrolling
HR+ HER2- Breast Cancer
Drug: Sapanisertib
Drug: Serabelisib

Phase 1, Phase 2

Faeth Therapeutics

Lone Tree, Colorado, United States and 6 other locations

A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...

Active, not recruiting
ER+ HER2- Advanced Breast Cancer
Drug: AZD9833 with palbociclib
Drug: AZD9833 with capivasertib

Phase 1

AstraZeneca
AstraZeneca

Aurora, Colorado, United States and 16 other locations

to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...

Active, not recruiting
Breast Cancer
Drug: vepdegestrant
Drug: PF-07220060

Phase 1, Phase 2

Pfizer
Pfizer

Loveland, Colorado, United States and 57 other locations

effective, when combined with chemotherapy, in treating people who has Human Epidermal Growth Factor Receptor 2 (HER2)-positive, early-stage breast...

Enrolling
Breast Cancer
HER2-positive Breast Cancer
Drug: Zanidatamab
Drug: Carboplatin

Phase 2

Jazz Pharmaceuticals
Jazz Pharmaceuticals

Denver, Colorado, United States and 34 other locations

Phase IB/II clinical trial of Alpelisb and Tucatinib in patients with PIK3CA-Mutant HER2-positive metastatic breast cancer....

Active, not recruiting
HER2-positive Metastatic Breast Cancer
Drug: Tucatinib
Drug: Fulvestrant

Phase 1, Phase 2

Criterium

Aurora, Colorado, United States and 3 other locations

to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...

Active, not recruiting
Breast Cancer
Drug: vepdegestrant
Drug: Samuraciclib

Phase 1, Phase 2

Pfizer
Pfizer

Loveland, Colorado, United States and 22 other locations

growth factor receptor 2 negative (ER+/HER2-) advanced/metastatic breast cancer. The phase 1b part of the trial will determine the ...

Active, not recruiting
Breast Cancer
Metastatic Breast Cancer
Drug: Alpelisib
Drug: Elacestrant

Phase 1, Phase 2

Stemline Therapeutics
Stemline Therapeutics

Lone Tree, Colorado, United States and 85 other locations

Locations recently updated

The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-...

Active, not recruiting
Metastatic Breast Cancer
Drug: Paclitaxel
Drug: Nab-paclitaxel

Phase 3

DualityBio

Aurora, Colorado, United States and 257 other locations

positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. The main pu...

Enrolling
Hormone-receptor-positive Breast Cancer
Hormone Receptor Positive HER-2 Negative Breast Cancer
Drug: Fulvestrant
Drug: BGB-43395

Phase 1

BeOne Medicines

Denver, Colorado, United States and 62 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems